Skip to main content
. 2018 Jan 9;18(1):164. doi: 10.3390/s18010164

Table 2.

Summary of acetylcholinesterase inhibition based biosensors.

Transducer Inhibitor (Drug) Detection Method Detection Limit Sample References
GCE/AuNPs-Si-SG/AchE Galantamine Cyclic voltammetry and amperometry - - [16]
Neostigmine
Pt/AchE Tacrine Chronoamperometry - - [18]
7-Methoxy-Tacrine (7-MEOTA)
Flow-through sensor/AchE Neostigmine Amperometric flow injection - - [70]
SPE/TTF/AchE Codeine Chronoamperometry - Urine and pharmaceutical tablets [71]
TTF-TCNQ-IL/AchE Neostigmine Chronoamperometry 0.3 nM (Neostigmine) Tap water [72]
Eserine 26 pM (Eserine)
GE/BODT-co-FMOC/Cho/AchE Neostigmine Amperometry 2.5 nM (Neostigmine) Tap water [73]
Donepezil 0.071 nM (Donepezil)
Flow-through sensor/AchE Neostigmine Amperometric flow injection - - [69]
Eserine
Tacrine
Donepezil
Rivastigmine
Pyridostigmine
Galantamine
SPE/MPs/AchE Galantamine Square wave voltammetry 1.5 µM - [74]

AuNPs: Gold nanoparticles; Si-SG: Silica sol-gel; TTF: Tetrathiafulvalene; TCNQ-IL: Tetracyanoquinodimethane ionic liquid gel; BODT-co-FMOC: 5,6-bis(octyloxy)-4,7-di(thiophen-2-yl)benzo[c][1,2,5]oxadiazole(BODT) with (2-(((9H-fluoren-9-yl)methoxy)carbonylamino) acetic acid (FMOC); SPE: Screen-printed electrode; MPs: Magnetic particles; AchE: Acetylcholinesterase.